Sites of action of CS-722, a newly synthesized centrally acting muscle relaxant. 1993

M Tanabe, and H Ishizuka, and T Murayama, and T Kaneko, and T Tonohiro, and J Sakai, and M Nagano, and K Sasahara, and N Iwata
New Lead Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan.

Sites of the muscle relaxant action of CS-722 were investigated in rats. Doses injected intra-4th ventricularly (i.c.v.) or intrathecally (i.t.) were determined according to measurements of CS-722 concentration in the brain stem and the spinal cord after systemic administration. When administered i.c.v. (50 and 100 micrograms) or i.t. (200 and 400 micrograms), CS-722 reduced the radio frequency decerebrate rigidity, although the effect after i.c.v. injection was transient. These results indicate that CS-722 exerts its muscle relaxant action by affecting both the supraspinal structure and the spinal cord. Spinal reflexes were not affected by CS-722 injected i.c.v. It seems that muscle relaxation is not always accompanied by impairment of the spinal reflex.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D008297 Male Males
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D009125 Muscle Relaxants, Central A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) Centrally Acting Muscle Relaxants,Central Muscle Relaxants,Relaxants, Central Muscle
D012018 Reflex An involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord.
D001933 Brain Stem The part of the brain that connects the CEREBRAL HEMISPHERES with the SPINAL CORD. It consists of the MESENCEPHALON; PONS; and MEDULLA OBLONGATA. Brainstem,Truncus Cerebri,Brain Stems,Brainstems,Cerebri, Truncus,Cerebrus, Truncus,Truncus Cerebrus
D003655 Decerebrate State A condition characterized by abnormal posturing of the limbs that is associated with injury to the brainstem. This may occur as a clinical manifestation or induced experimentally in animals. The extensor reflexes are exaggerated leading to rigid extension of the limbs accompanied by hyperreflexia and opisthotonus. This condition is usually caused by lesions which occur in the region of the brainstem that lies between the red nuclei and the vestibular nuclei. In contrast, decorticate rigidity is characterized by flexion of the elbows and wrists with extension of the legs and feet. The causative lesion for this condition is located above the red nuclei and usually consists of diffuse cerebral damage. (From Adams et al., Principles of Neurology, 6th ed, p358) Decerebrate Posturing,Decorticate Rigidity,Decorticate State,Rigidity, Decerebrate,Rigidity, Decorticate,Decerebrate Posturings,Decerebrate Rigidity,Decerebrate States,Decorticate Rigidities,Decorticate States,Posturing, Decerebrate,Posturings, Decerebrate,Rigidities, Decorticate,State, Decerebrate,States, Decerebrate
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M Tanabe, and H Ishizuka, and T Murayama, and T Kaneko, and T Tonohiro, and J Sakai, and M Nagano, and K Sasahara, and N Iwata
October 1992, Neuropharmacology,
M Tanabe, and H Ishizuka, and T Murayama, and T Kaneko, and T Tonohiro, and J Sakai, and M Nagano, and K Sasahara, and N Iwata
September 1992, Neuropharmacology,
M Tanabe, and H Ishizuka, and T Murayama, and T Kaneko, and T Tonohiro, and J Sakai, and M Nagano, and K Sasahara, and N Iwata
March 1998, General pharmacology,
M Tanabe, and H Ishizuka, and T Murayama, and T Kaneko, and T Tonohiro, and J Sakai, and M Nagano, and K Sasahara, and N Iwata
January 2006, CNS drug reviews,
M Tanabe, and H Ishizuka, and T Murayama, and T Kaneko, and T Tonohiro, and J Sakai, and M Nagano, and K Sasahara, and N Iwata
September 1968, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M Tanabe, and H Ishizuka, and T Murayama, and T Kaneko, and T Tonohiro, and J Sakai, and M Nagano, and K Sasahara, and N Iwata
September 1975, Neuropharmacology,
M Tanabe, and H Ishizuka, and T Murayama, and T Kaneko, and T Tonohiro, and J Sakai, and M Nagano, and K Sasahara, and N Iwata
November 1974, Archives internationales de pharmacodynamie et de therapie,
M Tanabe, and H Ishizuka, and T Murayama, and T Kaneko, and T Tonohiro, and J Sakai, and M Nagano, and K Sasahara, and N Iwata
July 1992, Chemical & pharmaceutical bulletin,
M Tanabe, and H Ishizuka, and T Murayama, and T Kaneko, and T Tonohiro, and J Sakai, and M Nagano, and K Sasahara, and N Iwata
January 1995, European journal of pharmacology,
M Tanabe, and H Ishizuka, and T Murayama, and T Kaneko, and T Tonohiro, and J Sakai, and M Nagano, and K Sasahara, and N Iwata
November 1970, Arzneimittel-Forschung,
Copied contents to your clipboard!